Status:
COMPLETED
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Chronic Liver Disease
HepatoCellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the feasibility to stratify liver fibrosis in patients with chronic liver disease through non-invasive, spectral CT.
Detailed Description
This is a retrospective study, in which a FDA approved imaging device (spectral CT scanner) currently used for several clinical applications will be evaluated for feasibility of studying chronic liver...
Eligibility Criteria
Inclusion
- Adult patient with chronic liver disease undergoing CT scan for/suspicion of hepatocellular carcinoma.
- Patients should be scheduled for/or should have obtained a multiphasic MRI of the liver.
Exclusion
- Patients \< 18 years old.
- History of allergy to intravenous contrast.
- Patients at risk for contrast-induced-nephropathy,
- Pregnant patients.
Key Trial Info
Start Date :
November 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01825213
Start Date
November 1 2013
End Date
October 1 2016
Last Update
April 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital,
Boston, Massachusetts, United States, 02114